1. Expression and role of cocaine-amphetamine regulated transcript (CART) in the proliferation of biliary epithelium
   Arianna Casini et al, 2023, European Journal of Histochemistry CrossRef
2. Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides
   Veronika Strnadová et al, 2024, Bioscience Reports CrossRef
3. New Uses of Melatonin as a Drug; A Review
   Miroslav Pohanka, 2022, Current Medicinal Chemistry CrossRef
4. Cocaine-amphetamine regulated transcript (CART) — promising omics breakthrough in the endocrinology
   R. K. Mikheev et al, 2022, Problems of Endocrinology CrossRef
5. Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
   Chongyun Wu et al, 2022, Inflammation and Regeneration CrossRef
6. Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging
   Xinyi Gu et al, 2021, Biomedicine & Pharmacotherapy CrossRef
7. Irisin Acts via the PGC-1α and BDNF Pathway to Improve Depression-like Behavior
   Danbi Jo et al, 2021, Clinical Nutrition Research CrossRef
8. Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease
   Rajesh Ranganathan et al, 2023, Translational Medicine of Aging CrossRef
9. The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges
   Jiaxuan He et al, 2023, Biomedicine & Pharmacotherapy CrossRef
10. Oxygen metabolism abnormality and Alzheimer's disease: An update
    Guangdong Liu et al, 2023, Redox Biology CrossRef
11. To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis
    Yuan Li et al, 2023, Frontiers in Aging Neuroscience CrossRef
12. “Vitaction” deficiency: a possible root cause for multiple lifestyle disorders including Alzheimer’s disease
    Milind Watve et al, 2024, Exploration of Neuroprotective Therapy CrossRef
13. Experimental approaches for altering the expression of Abeta‐degrading enzymes
    David A. Loeffler, 2023, Journal of Neurochemistry CrossRef
14. Alzheimer’s Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links
    Min Zhang et al, 2023, Life CrossRef
15. HIF-1 signalling pathway was identified as a potential new pathway for Icariin’s treatment against Alzheimer’s disease based on preclinical evidence and bioinformatics
    Mingyao You et al, 2022, Frontiers in Pharmacology CrossRef